You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 236 No. 10, September 6, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ultrasound Examination of the Gallbladder

An Alternative to "Double-Dose" Oral Cholecystography

Royal J. Bartrum, Jr, MD; Harte C. Crow, MD; Sheila R. Foote, RT

JAMA. 1976;236(10):1147-1148.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE LONG-APPRECIATED problem of poor gallbladder visualization following a single dose of an orally administered contrast agent continues to stimulate controversy. None of the various orally administered agents consistently gives satisfactory opacification with standard dosage. Nearly everyone agrees that the traditional remedy of a "double dose" (actually a repeat single dose) is costly in both physician and patient time, as well as in increased radiation exposure. Some physicians advocate using a "double dose" initially.1,2 Others believe that this is wasteful, because it subjects the majority of patients to unnecessary overdosage, and prefer diet modifications, oral cholecystogogues, or bile salts.3

We believe that ultrasonic examination of the initially nonvisualized gallbladder is superior to any of these suggestions.

Materials and Methods

Fifty patients with a nonvisualized gallbladder following a single 3-gm dose of tyropanoate sodium (Bilopaque) were examined with a commercially available bistable B-scanner and a 2.25-MHz transducer. The ultrasound . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Radiology, Dartmouth Medical School, Mary Hitchcock Memorial Hospital, Hanover, NH.


Footnotes

Reprint requests to Department of Radiology, Dartmouth Medical School, Hanover, NH 03755 (Dr Bartrum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.